You are here: Industry Insights > Novel Coronavirus Pneumonia

News List

Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia PRNewswire
February 27, 2020
Ascletis Pharma Inc. (HKEX code: 1672) announces today the advancement in Novel Coronavirus Pneumonia clinical trial of oral Ganovo® and Ritonavir combination therapy, led by Dr. Hongyi CHEN, the director of the Ninth Hospital of Nanchang.
Which Will Claim the Real "Magic Medicine" Among 3 "Specific Medicines" against Novel Coronavirus Pneumonia PharmaSources/Mi Ling
February 25, 2020
Challenge Contest of "Specific Medicines" against Novel Coronavirus Pneumonia - Which Will Claim the Real "Magic Medicine" in Such 1/3 Competition?
NHC: Early Diagnosis and Treatment Brings the Proportion of Severe NCP Cases Down from 38% to 18% fmprc
February 19, 2020
On the afternoon of 17 February, the State Council inter-agency task force on responding to the novel coronavirus pneumonia (NCP, or COVID-19) outbreak held a press briefing on the latest progress in medical treatment of NCP cases.
A Summary and Interpretation of the Progress of Clinical Trials Relating to the Novel Coronavirus Pneumonia (2) PharmaSources/Zhulikou431
February 14, 2020
The collection time of the information summarized above is Feb. 2, 2020, which will change with the progress of scientific research.
A Summary and Interpretation of the Progress of Clinical Trials Relating to the Novel Coronavirus Pneumonia (1) PharmaSources/zhulikou431
February 14, 2020
The novel coronavirus pneumonia incident that started to occur in Wuhan City, Hubei Province from Dec. 2019 has produced continuous impacts on the Chinese people.